Top compounds associated with response to TSR2


Feature Type Standardized
Nominal ANOVA
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.16 5e-07
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 1e-06
mRNA CHIR-99021 GDSC1000 pan-cancer AAC -0.15 2e-06
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.16 3e-06
mRNA PD318088 CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA AZ628 GDSC1000 pan-cancer AAC -0.22 3e-06
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.16 3e-06
mRNA AZD7762 GDSC1000 pan-cancer AAC -0.14 7e-06
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.15 8e-06
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 1e-05
Download CSV